In addition, we investigated the immune suppressive activity of BMDM toward T cell proliferation in gliomas, and found that it increases from the marginal to the central region of the tumor (24) but, to the best of our knowledge, this information for BrM is, to some extent, conflicting and limited to mouse models. This evidence concerns the gene SMARCA2 and neoplasm.